Plantibodies
PrivateLast Round
Angel
Jan 8, 2026
Total Funding Raised
$1.4M
Company Overview
Plantibodies is a biotechnology company that develops a proprietary platform for the oral delivery of biologics using plant-based expression systems and bioencapsulation to treat gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plantibodies Comparables
Compare Plantibodies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gastrobody Therapeutics | 87% | |
| Intract Pharma | 87% | |
| Vivtex | 71% |
Plantibodies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 8, 2026 | ||||
| Grant | Jun 27, 2023 | ||||
| Pre Seed | Apr 11, 2023 | ||||
| Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
Plantibodies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Île-de-France | Grant |
| Les Business Angels des Grandes Écoles | Angel |
| Angels Santé | Angel |
| Bpifrance | Pre Seed |
| Investessor | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 48% MoM.
- Jun 27, 2023
$440K grant received from Région Île-de-France.
Plantibodies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Plantibodies's valuation, stock price, and market status.
Is Plantibodies a public or private company?
Plantibodies is a private company.
What is the current stock price of Plantibodies?
Plantibodies is a private company with no public stock price. No recent secondary market data is available.
How much is Plantibodies worth (valuation)?
Valuation information for Plantibodies is not publicly available.
Can I buy Plantibodies stock?
Plantibodies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Plantibodies's last funding round?
Plantibodies's most recent funding round was Angel on January 8, 2026.
Who are the main investors in Plantibodies?
Key investors in Plantibodies include Région Île-de-France, Les Business Angels des Grandes Écoles, Angels Santé, Bpifrance, Investessor.
Will Plantibodies IPO soon?
No public IPO plans have been announced for Plantibodies.
How can I track Plantibodies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plantibodies's secondary market activity and sign up for updates.